Starting out with an FDA-approved drug library, our research group used a necroptosis-sensitive cell line L929-FADD-KO, for screening of 1068 drugs, and the results showed that menadione could effectively induce PCD, with great potential to be a potential anti-cancer drug. The gene discussed is FADD; the disease is cancer.